ID
ABBV icon

Integral Derivatives’s AbbVie ABBV Stock Holding History

Integral Derivatives’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.56M Sell
16,500
-44,300
-73% -$4.87M 0.04% 161
2017
Q4 		$5.88M Buy
60,800
+19,900
+49% +$1.88M 0.12% 93
2017
Q3 		$3.63M Sell
40,900
-6,700
-14% -$510K 0.07% 191
2017
Q2 		$3.45M Buy
47,600
+200
+0.4% +$13.4K 0.07% 174
2017
Q1 		$3.09M Buy
47,400
+10,700
+29% +$673K 0.06% 219
2016
Q4 		$2.3M Buy
36,700
+9,400
+34% +$574K 0.04% 289
2016
Q3 		$1.72M Buy
27,300
+400
+1% +$25.9K 0.04% 303
2016
Q2 		$1.67M Sell
26,900
-900
-3% -$54.8K 0.04% 278
2016
Q1 		$1.59M Sell
27,800
-11,200
-29% -$624K 0.05% 265
2015
Q4 		$2.31M Buy
39,000
+9,400
+32% +$541K 0.06% 238
2015
Q3 		$1.61M Buy
29,600
+16,500
+126% +$1.07M 0.04% 364
2015
Q2 		$880K Sell
13,100
-19,000
-59% -$1.24M 0.02% 561
2015
Q1 		$1.88M Buy
32,100
+12,800
+66% +$773K 0.04% 301
2014
Q4 		$1.26M Buy
+19,300
New +$1.22M 0.02% 595
2014
Q3 		– Sell
-21,000
Closed -$1.19M – 1378
2014
Q2 		$1.19M Buy
21,000
+10,000
+91% +$525K 0.02% 621
2014
Q1 		$565K Buy
+11,000
New +$556K 0.01% 855

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's ABBV Position: Q4 2017 in Review

Integral Derivatives sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 28,024 shares — an estimated $2.64M sold.

Integral Derivatives first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $2.49M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Integral Derivatives reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 28,024 AbbVie shares in Q4 2017, an estimated $2.64M.
  • Integral Derivatives first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
  • Integral Derivatives's AbbVie position peaked at $2.49M in Q3 2017.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.